ENLV
Price
$1.82
Change
+$0.04 (+2.25%)
Updated
Aug 15 closing price
Capitalization
43.41M
2 days until earnings call
SLNO
Price
$71.63
Change
-$5.73 (-7.41%)
Updated
Aug 15 closing price
Capitalization
3.81B
81 days until earnings call
Interact to see
Advertisement

ENLV vs SLNO

Header iconENLV vs SLNO Comparison
Open Charts ENLV vs SLNOBanner chart's image
Enlivex Therapeutics
Price$1.82
Change+$0.04 (+2.25%)
Volume$2.29M
Capitalization43.41M
Soleno Therapeutics
Price$71.63
Change-$5.73 (-7.41%)
Volume$7.29M
Capitalization3.81B
ENLV vs SLNO Comparison Chart in %
Loading...
ENLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENLV vs. SLNO commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENLV is a Hold and SLNO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (ENLV: $1.82 vs. SLNO: $71.63)
Brand notoriety: ENLV and SLNO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENLV: 744% vs. SLNO: 506%
Market capitalization -- ENLV: $43.41M vs. SLNO: $3.81B
ENLV [@Biotechnology] is valued at $43.41M. SLNO’s [@Biotechnology] market capitalization is $3.81B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENLV’s FA Score shows that 1 FA rating(s) are green whileSLNO’s FA Score has 0 green FA rating(s).

  • ENLV’s FA Score: 1 green, 4 red.
  • SLNO’s FA Score: 0 green, 5 red.
According to our system of comparison, both ENLV and SLNO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENLV’s TA Score shows that 5 TA indicator(s) are bullish while SLNO’s TA Score has 4 bullish TA indicator(s).

  • ENLV’s TA Score: 5 bullish, 4 bearish.
  • SLNO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ENLV is a better buy in the short-term than SLNO.

Price Growth

ENLV (@Biotechnology) experienced а +27.27% price change this week, while SLNO (@Biotechnology) price change was -13.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.90%. For the same industry, the average monthly price growth was +26.70%, and the average quarterly price growth was +20.91%.

Reported Earning Dates

ENLV is expected to report earnings on Aug 18, 2025.

SLNO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+9.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNO($3.81B) has a higher market cap than ENLV($43.4M). SLNO YTD gains are higher at: 59.355 vs. ENLV (55.556). ENLV has higher annual earnings (EBITDA): -14.04M vs. SLNO (-194.63M). SLNO has more cash in the bank: 290M vs. ENLV (20.6M). ENLV has less debt than SLNO: ENLV (503K) vs SLNO (52.8M). ENLV (0) and SLNO (0) have equivalent revenues.
ENLVSLNOENLV / SLNO
Capitalization43.4M3.81B1%
EBITDA-14.04M-194.63M7%
Gain YTD55.55659.35594%
P/E RatioN/AN/A-
Revenue00-
Total Cash20.6M290M7%
Total Debt503K52.8M1%
FUNDAMENTALS RATINGS
ENLV vs SLNO: Fundamental Ratings
ENLV
SLNO
OUTLOOK RATING
1..100
2353
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
73
Overvalued
PROFIT vs RISK RATING
1..100
10048
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
3644
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5025

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENLV's Valuation (26) in the Medical Specialties industry is somewhat better than the same rating for SLNO (73). This means that ENLV’s stock grew somewhat faster than SLNO’s over the last 12 months.

SLNO's Profit vs Risk Rating (48) in the Medical Specialties industry is somewhat better than the same rating for ENLV (100). This means that SLNO’s stock grew somewhat faster than ENLV’s over the last 12 months.

ENLV's SMR Rating (97) in the Medical Specialties industry is in the same range as SLNO (98). This means that ENLV’s stock grew similarly to SLNO’s over the last 12 months.

ENLV's Price Growth Rating (36) in the Medical Specialties industry is in the same range as SLNO (44). This means that ENLV’s stock grew similarly to SLNO’s over the last 12 months.

ENLV's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as SLNO (100). This means that ENLV’s stock grew similarly to SLNO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENLVSLNO
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 6 days ago
87%
Declines
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ENLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OGMNX38.980.49
+1.27%
Invesco Gold & Special Minerals R
BPLEX10.730.02
+0.19%
Boston Partners Long/Short Equity Inv
FDYZX209.06-0.26
-0.12%
Franklin DynaTech Adv
HFDTX19.31-0.04
-0.21%
Hartford Schroders US MidCap Opps R5
WOOSX18.42-0.13
-0.70%
JPMorgan SMID Cap Equity R6

ENLV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENLV has been loosely correlated with APVO. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ENLV jumps, then APVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENLV
1D Price
Change %
ENLV100%
+2.25%
APVO - ENLV
39%
Loosely correlated
-1.96%
FATE - ENLV
32%
Poorly correlated
+1.87%
VKTX - ENLV
30%
Poorly correlated
-0.52%
SLNO - ENLV
29%
Poorly correlated
-7.41%
AXON - ENLV
29%
Poorly correlated
+0.59%
More